9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
QuantumLeap Healthcare Collaborative
Eli Lilly and Company
OHSU Knight Cancer Institute
Emory University
City of Hope Medical Center
Roswell Park Cancer Institute